isolated compound, pharmaceutical composition, method of treating or preventing at least one of the following diseases, disorders or conditions, and method of treating or preventing a circadian rhythm disorder or circadian component disorder in an individual
Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.